Beste Christian, Stock Ann-Kathrin, Epplen Jörg T, Arning Larissa
Cognitive Neurophysiology, Department of Child and Adolescent Psychiatry, Faculty of Medicine of the TU Dresden, Germany.
Cognitive Neurophysiology, Department of Child and Adolescent Psychiatry, Faculty of Medicine of the TU Dresden, Germany.
Eur Neuropsychopharmacol. 2016 Jun;26(6):1029-36. doi: 10.1016/j.euroneuro.2016.03.002. Epub 2016 Mar 9.
Action control is achieved through a multitude of cognitive processes. One of them is the ability to inhibit responses, for which the dopaminergic systems is known to play an important role. Many lines of psychophysiological research substantiate that two distinct response inhibition subprocesses exist, but it has remained elusive whether they can be attributed to distinct neurobiological factors governing the dopaminergic system. We, therefore, investigated this question by examining the effects of DRD1 (rs4532) and DRD2 (rs6277) receptor polymorphisms on electrophysiological correlates of response inhibition subprocesses (i.e., Nogo-N2 and Nogo-P3) in 195 healthy human subjects with a standard Go/Nogo task. The results show that response inhibition performance at a behavioral level is affected by DRD1 and DRD2 receptor variation. However, from an electrophysiological point of view these effects emerge via different mechanisms selectively affected by DRD1 and DRD2 receptor variation. While the D1 receptor system is associated with pre-motor inhibition electrophysiological correlates of response inhibition processes (Nogo-N2), the D2 receptor system is associated with electrophysiological correlates of outcome evaluation processes. Dissociable cognitive-neurophysiological subprocesses of response inhibition are hence attributable to distinct dopamine receptor systems.
动作控制是通过多种认知过程实现的。其中之一是抑制反应的能力,已知多巴胺能系统在这方面发挥重要作用。许多心理生理学研究表明,存在两个不同的反应抑制子过程,但它们是否可归因于控制多巴胺能系统的不同神经生物学因素仍不清楚。因此,我们通过研究DRD1(rs4532)和DRD2(rs6277)受体多态性对195名健康人类受试者在标准Go/NoGo任务中反应抑制子过程(即Nogo-N2和Nogo-P3)的电生理相关性的影响来探讨这个问题。结果表明,行为水平上的反应抑制表现受DRD1和DRD2受体变异的影响。然而,从电生理学角度来看,这些影响是通过受DRD1和DRD2受体变异选择性影响的不同机制出现的。虽然D1受体系统与反应抑制过程(Nogo-N2)的运动前抑制电生理相关性有关,但D2受体系统与结果评估过程的电生理相关性有关。因此,反应抑制中可分离的认知神经生理子过程可归因于不同的多巴胺受体系统。